10 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio

In this article, we will take a look at the 10 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio. To skip our analysis of Ray Dalio’s profile, investment strategy, and 13F holdings, you can go directly to see the 5 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio.

With a net worth estimated at $19.1 billion, Ray Dalio is the founder and co-chief investment officer of Bridgewater Associates LP, the world’s largest hedge fund. Apart from a very successful investment career, Ray Dalio is also the #1 New York Times bestselling author of Principles: Life and Work, Principles for Dealing with the Changing World Order, and Principles for Navigating Big Debt Crises.

Ray Dalio graduated with a BS in Finance from C.W. Post College in 1971 and earned an MBA degree from Harvard Business School in 1973. After short stints at Dominick & Dominick LLC and Shearson Hayden Stone, Ray founded Bridgewater Associates LP in 1975. Bridgewater Associates has since grown significantly to become the largest hedge fund in the world with $151 billion in assets under management, as of December 31, 2021.

Bridgewater Associates focuses on three main investment strategies for its funds: Pure Alpha strategy, All Weather strategy, and the Optimal Portfolio strategy. It structures portfolios in a manner designed to produce consistent and uncorrelated returns based on risk allocations. Bridgewater Associates’ flagship fund, Pure Alpha has returned an average of 11.4% annually since its inception in 1991.

As of Q2 2022, the 13F portfolio of Ray Dalio’s Bridgewater Associates was valued at $23.6 billion and comprised of 1081 total positions. During the second quarter, the hedge fund added 116 new positions, increased exposure to 728 positions, reduced exposure to 352 positions and exited out of 97 positions.

The list of 10 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio accounted for 22.72% of the portfolio weight, with the highest concentration in The Procter & Gamble Company (NYSE:PG), accounting for 4.11% of the portfolio weight.

Blue chip stocks are generally well known stocks that are leaders in their sectors. Given their earnings power, scale, and strong fundamentals, many blue chips tend to do well over the long term.

Recently, the market has declined due to the Federal Reserve increasing interest rates and the increasing potential for an economic slowdown. If economic data continues to miss expectations, stocks could continue to fall further. Nevertheless, there could be opportunity for long term investors who buy quality blue chip companies given the low valuations.

best dividend stocks according to Ray Dalio

Ray Dalio of Bridgewater Associates

Methodology

For our list, we took 10 stocks from Ray Dalio’s Bridgewater Associates’13F portfolio at the end of Q2 2022 that we think have the right mixture of industry leadership, strong fundamentals, and growth potential. We then ranked them from #10 to #1 based on the stake value of Bridgewater Associates portfolio in those stocks in the second quarter. We also provided the number of hedge funds in our database that held shares in the stock at the end of Q2 2022.

10 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio

10. Colgate-Palmolive Company (NYSE:CL)

Bridgewater Associates’ Stake Value: $183,536,000

Percentage of Bridgewater Associates’ 13F Portfolio: 0.77%

Number of Hedge Fund Holders: 55

Colgate-Palmolive Company (NYSE:CL) is a leading global consumer products company focused on Oral Care, Personal Care, Home Care and Pet Nutrition products sold across more than 200 countries and territories.

Bridgewater Associates holds 2,290,197 shares of Colgate-Palmolive Company (NYSE:CL), making up 0.77% of the hedge fund’s 13F portfolio. Bridgewater Associates’ stake decreased by 13% in Q2 2022, compared to the previous quarter. The company ranks #10 on our list of 10 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio.

Colgate-Palmolive Company (NYSE:CL) announced in August that it has entered into an agreement for the acquisition of three dry pet food manufacturing plants in the U.S. from Red Collar Pet Foods for $700 million to support its Hill’s Pet Nutrition business. In September, the board of directors of Colgate-Palmolive Company (NYSE:CL) declared a quarterly cash dividend of $0.47 per share. The company has paid uninterrupted dividends on its common stock since 1895.

As of Q2 2022, 55 hedge funds out of the 895 hedge funds tracked by Insider Monkey were bullish on Colgate-Palmolive Company (NYSE:CL) and held its shares valued at $2.9 billion. First Eagle Investment Management was the largest shareholder holding 11.2 million shares valued at $900 million.

Here is what First Eagle Investments Global Fund said about Colgate-Palmolive Company (NYSE:CL) in its Q2 2022 investor letter:

“Shares of consumer staples giant Colgate-Palmolive have performed well as investors rotated into more recessionary-resilient defensive stocks amid the broader selloff during the second quarter. The company raised revenue guidance for 2022 but lowered its margin outlook because of higher costs for raw materials, packaging and logistics; we believe that the company’s size and market share provide it with options to mitigate the inflation challenges it faces. We continue to like Colgate- Palmolive’s dividend and previously announced $5 billion stock buyback program.”

Alongside The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG), Colgate-Palmolive Company (NYSE:CL) is a blue chip holding in billionaire Ray Dalio’s Bridgewater Associates’ portfolio at the end of Q2 2022.

9. Medtronic plc (NYSE:MDT)

Bridgewater Associates’ Stake Value: $224,847,000

Percentage of Bridgewater Associates’ 13F Portfolio: 0.95%

Number of Hedge Fund Holders: 54

Based in Dublin, Ireland, Medtronic plc (NYSE:MDT) is a leading healthcare technology company with a focus on providing technologies and therapies including cardiac devices, surgical robotics, insulin pumps, surgical tools, and patient monitoring systems, among others. Medtronic plc (NYSE:MDT) employs a global team of over 95,000 people across more than 150 countries.

Ray Dalio’s Bridgewater Associates owns 2,505,256 shares in Medtronic plc (NYSE:MDT), accounting for 0.95% of the hedge fund’s 13F portfolio. The hedge fund doubled down on its investment in Medtronic plc (NYSE:MDT) in Q2 2022 and increased its stake by 34%, as compared to the previous quarter.

Earlier in September, RBC Capital analyst Shagun Singh lowered the price target on Medtronic plc (NYSE:MDT) shares to $110 from $122 but retained an ‘Outperform’ rating on the shares. The analyst remains positive on the long-term prospects of the stock.

According to the Insider Monkey data tracking 895 hedge funds, 54 hedge funds were long Medtronic plc (NYSE:MDT) as of Q2 2022, holding shares with total value of $2.5 billion. Its largest shareholder was Arrowstreet Capital with ownership of 3.8 million shares valued at $338 million.

8. Starbucks Corporation (NASDAQ:SBUX)

Bridgewater Associates’ Stake Value: $247,711,000

Percentage of Bridgewater Associates’ 13F Portfolio: 1.04%

Number of Hedge Fund Holders: 55

Seattle, Washington-based Starbucks Corporation (NASDAQ:SBUX) is a multinational chain of coffeehouses and roastery reserves with more than 34,000 stores in 84 markets across the world. With a history dating back to 1971, Starbucks Corporation (NASDAQ:SBUX) caters to millions of customers every day.

Ray Dalio’s Bridgewater Associates owns 3,242,719 shares of Starbucks Corporation (NASDAQ:SBUX), accounting for 1.04% of its 13F portfolio. The hedge fund has increased its stake by 27% in the coffeemaker during the first half of 2022.

In September, Starbucks Corporation (NASDAQ:SBUX) announced a 3-year ‘Reinvention Plan’ to deliver 10-12% annual revenue growth and 15-20% EPS growth. Recently, Piper Sandler analyst Nicole Regan raised the price target on Starbucks Corporation (NASDAQ:SBUX) shares to $92 from $84 and kept a ‘Neutral’ rating on the shares.

As of Q2 2022, 55 of the 895 hedge funds tracked by Insider Monkey owned shares of Starbucks Corporation (NASDAQ:SBUX), valued at $1.4 billion. Its largest shareholder was Ken Griffin’s Citadel Investment Group.

7. McDonald’s Corporation (NYSE:MCD)

Bridgewater Associates’ Stake Value: $511,433,000

Percentage of Bridgewater Associates’ 13F Portfolio: 2.16%

Number of Hedge Fund Holders: 50

Based in Chicago, Illinois, McDonald’s Corporation (NYSE:MCD) is a leading global foodservice retailer with nearly 40,000 locations in over 100 countries. With a history dating back to 1955, McDonald’s Corporation (NYSE:MCD) is famous for its food items such as Big Mac, Quarter Pounder, Chicken McNuggets and Egg McMuffin.

Ray Dalio’ Bridgewater Associates owns 2,071,584 shares of McDonald’s Corporation (NYSE:MCD), accounting for 2.16% of its 13F portfolio. The hedge fund decreased its stake by 11% in Q2 2022, as compared to the previous quarter.

In September, Piper Sandler analyst Nicole Miller Regan reaffirmed an ‘Overweight’ rating and increased the price target to $270 from $263 for shares of McDonald’s Corporation (NYSE:MCD).

As of Q2 2022, McDonald’s Corporation (NYSE:MCD) shares were held by 50 of the 895 hedge funds tracked by Insider Monkey, for a total value of $2.3 billion. Arrowstreet Capital was the second largest hedge fund shareholder after Bridgewater Associates, with ownership of 1.7 million shares valued at $410 million.

6. Walmart Inc. (NYSE:WMT)

Bridgewater Associates’ Stake Value: $571,146,000

Percentage of Bridgewater Associates’ 13F Portfolio: 2.42%

Number of Hedge Fund Holders: 67

Bentonville, Arkansas-based Walmart Inc. (NYSE:WMT) is a leading global discount retailer operating more than 10,500 stores and clubs under 46 banners in 24 countries and eCommerce websites.

Ray Dalio’s Bridgewater Associates owns 4,697,701 shares of Walmart Inc. (NYSE:WMT), accounting for 2.42% of its 13F portfolio. The hedge fund increased its stake by 17% in Q2 2022, as compared to the previous quarter.

Earlier this year in August, Walmart Inc. (NYSE:WMT) released its financial results for the quarter ended July 31, 2022. Its total revenue increased by 8% y-o-y to $153 billion, while its net income surged by 20% y-o-y to $5.1 billion, for the three months. The normalized EPS was recorded at $1.77 for the quarter, beating the consensus by $0.17.

As of Q2 2022, 67 of the 895 hedge funds tracked by Insider Monkey were long Walmart Inc. (NYSE:WMT), holding shares worth $3.8 billion. Its largest hedge fund shareholder is GQG Partners with ownership of 9.8 million shares valued at $1.2 billion.

Like Walmart Inc. (NYSE:WMT), The Coca-Cola Company (NYSE:KO), Johnson & Johnson (NYSE:JNJ), and The Procter & Gamble Company (NYSE:PG) are among billionaire Ray Dalio’s Bridgewater Associates’ blue chip holdings at the end of Q2 2022.

Click to continue reading and see 5 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio.

Suggested Articles:

10 Best Dividend Stocks to Buy According to Billionaire Howard Marks

10 Best Stocks Under $10 to Buy Right Now

15 Best Energy Stocks to Buy Now

Disclosure: None. 10 Blue Chip Stocks to Buy Now According to Billionaire Ray Dalio is originally published on Insider Monkey.